JMJoão João Mendes

João João Mendes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


João João Mendes has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Abordagem à Vítima com Suspeita de Sépsis ou Choque Séptico: Recomendações Clínicas para o Contexto Pré-Hospitalar Português

    by Adelaide Moutinho, Fábio Martins, Joana Fontes, José Lopes, Lénia Ferreira, Solange Mega, Ana Vaz Cristino, Eduardo Cernadas, Francisco Abecasis, João Gonçalves Pereira, et al.

    A sépsis é uma emergência médica tempo-dependente, associada a elevada morbilidade e mortalidade. O reconhecimento precoce e a abordagem adequada no pré-hospitalar são determinantes para o prognóstico. Apesar da existência da via verde de sépsis normatizada pela Direção-Geral da Saúde, verificou-se a subnotificação dos casos de suspeita de sépsis, urgindo a necessidade de revisão dos critérios de alerta. Além disso, faltavam em Portugal orientações específicas para a sua ativação e gestão no contexto pré-hospitalar. Por esse motivo, este artigo visa estabelecer recomendações baseadas na evidência para a uniformização do reconhecimento e tratamento da sépsis e do choque séptico no pré-hospitalar português, alinhadas com as orientações internacionais mais recentes e com as capacidades operacionais do Sistema Integrado de Emergência Médica. A presente orientação técnica resultou de uma revisão exaustiva da literatura, integrando consensos internacionais e adaptando-os à realidade nacional. Deste modo, são definidos critérios de inclusão e exclusão para o alerta de sépsis em contexto pré-hospitalar, priorizando a identificação precoce através da suspeita de infeção ou alterações da temperatura e disfunção orgânica ou indicadores clínicos de gravidade, como National Early Warning Score (NEWS)/NEWS2 ≥ 5, Índice de Choque ≥ 0,7, Mottling ≥ 2, tempo de preenchimento capilar > 2 segundos. O tratamento depende do tipo de meio interveniente, incluindo oxigenoterapia, posicionamento e controlo de temperatura para meios de suporte básico de vida; cristaloides balanceados, antipiréticos parentéricos e início precoce de suporte vasopressor para meios diferenciados, mediante algumas premissas para os meios de suporte imediato de vida. Recomenda-se ainda a antibioterapia empírica nos casos de choque séptico abordados por meios com médico, nomeadamente Viaturas Médicas de Emergência e Reanimação e Serviço de Helicópteros de Emergência Médica. O documento uniformiza também os registos clínicos e a ativação de alertas através do iTeams® e do Verbete Nacional de Socorro. Esta primeira orientação técnica nacional para a sépsis no pré-hospitalar estabelece procedimentos uniformes e baseados na evidência para o reconhecimento e tratamento precoces neste contexto, contribuindo para a melhoria dos resultados clínicos, otimização de recursos e reforço da articulação inter-hospitalar no âmbito da via verde de sépsis.

  • Open Access

    How to Unleash the Potential of the Portuguese Registry of Intensive Care Medicine?

    by João João Mendes, Inês Amaral, João Gonçalves Pereira, José Artur Paiva, Paulo Figueiredo, Pedro Póvoa, Teresa Guimarães, Paulo Mergulhão, On behalf of the RNMI Study Group


  • Open Access

    Update of the recommendations of the Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group for the approach to COVID-19 in Intensive Care Medicine

    by João João Mendes, José Artur Paiva, Filipe Gonzalez, Paulo Mergulhão, Filipe Froes, Roberto Roncon, João Gouveia

    The Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group have previously issued health service and management recommendations for critically ill patients with COVID-19. Due to the evolution of knowledge, the panel of experts was again convened to review the current evidence and issue updated recommendations. A national panel of experts who declared that they had no conflicts of interest regarding the development of the recommendations was assembled. Operational questions were developed based on the PICO methodology, and a rapid systematic review was conducted by consulting different bibliographic sources. The panel determined the direction and strength of the recommendations using two Delphi rounds, conducted in accordance with the principles of the GRADE system. A strong recommendation received the wording “is recommended”, and a weak recommendation was written as “is suggested.” A total of 48 recommendations and 30 suggestions were issued, covering the following topics: diagnosis of SARS-CoV-2 infection, coinfection and superinfection; criteria for admission, cure and suspension of isolation; organization of services; personal protective equipment; and respiratory support and other specific therapies (antivirals, immunomodulators and anticoagulation). These recommendations, specifically oriented to the Portuguese reality but that may also apply to Portuguese-speaking African countries and East Timor, aim to support health professionals in the management of critically ill patients with COVID-19. They will be continuously reviewed to reflect the progress of our understanding and the treatment of this pathology.


  • Open Access

    Recommendations from the Sociedade Portuguesa de Cuidados Intensivos and Infection & Sepsis Group for intensive care approach to COVID-19

    by Joã£O Joã£O Mendes, Paulo Mergulhã£O, Filipe Froes, Josã© Artur Paiva, Joã£O Gouveia

    Current COVID-19 epidemics was declared on December 31, 2019 at the Wuhan city seafood market, rapidly spreading throughout China, and later reaching several countries (mainly South Korea, Japan, Italy and Iran) and, since March 1, reaching Portugal. Most of the infected patients present with mild symptoms, not requiring hospitalization. Among those admitted to the hospital, 6% to 10% require admission to the intensive care unit. These recommendations are aimed to support the organization of intensive care services to respond COVID-19, providing optimized care to the patient and protection for healthcare professionals.


  • Open Access

    Sociedade Portuguesa de Cuidados Intensivos guidelines for stress ulcer prophylaxis in the intensive care unit

    by João João Mendes, Mário Jorge Silva, Luís Silva Miguel, Maria Albertina Gonçalves, Maria João Oliveira, Catarina da Luz Oliveira, João Gouveia

    Critically ill patients are at risk of developing stress ulcers in the upper digestive tract. Agents that suppress gastric acid are commonly prescribed to reduce the incidence of clinically important stress ulcer-related gastrointestinal bleeding. However, the indiscriminate use of stress ulcer prophylaxis in all patients admitted to the intensive care unit is not warranted and can have potential adverse clinical effects and cost implications. The present guidelines from the Sociedade Portuguesa de Cuidados Intensivos summarizes the current evidence and gives six clinical statements and an algorithm aiming to provide a standardized prescribing policy for the use of stress ulcer prophylaxis in the intensive care unit.


  • Open Access

    Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections

    by Carla Mottola, Carina S. Matias, João J. Mendes, José Melo-Cristino, Luís Tavares, Patrícia Cavaco-Silva, Manuela Oliveira

    Foot infections are a major cause of morbidity in people with diabetes and the most common cause of diabetes-related hospitalization and lower extremity amputation. Staphylococcus aureus is by far the most frequent species isolated from these infections. In particular, methicillin-resistant S. aureus (MRSA) has emerged as a major clinical and epidemiological problem in hospitals. MRSA strains have the ability to be resistant to most β-lactam antibiotics, but also to a wide range of other antimicrobials, making infections difficult to manage and very costly to treat. To date, there are two fifth-generation cephalosporins generally efficacious against MRSA, ceftaroline and ceftobripole, sharing a similar spectrum. Biofilm formation is one of the most important virulence traits of S. aureus. Biofilm growth plays an important role during infection by providing defence against several antagonistic mechanisms. In this study, we analysed the antimicrobial susceptibility patterns of biofilm-producing S. aureus strains isolated from diabetic foot infections. The antibiotic minimum inhibitory concentration (MIC) was determined for ten antimicrobial compounds, along with the minimum biofilm inhibitory concentration (MBIC) and minimum biofilm eradication concentration (MBEC), followed by PCR identification of genetic determinants of biofilm production and antimicrobial resistance. Results demonstrate that very high concentrations of the most used antibiotics in treating diabetic foot infections (DFI) are required to inhibit S. aureus biofilms in vitro, which may explain why monotherapy with these agents frequently fails to eradicate biofilm infections. In fact, biofilms were resistant to antibiotics at concentrations 10–1000 times greater than the ones required to kill free-living or planktonic cells. The only antibiotics able to inhibit biofilm eradication on 50 % of isolates were ceftaroline and gentamicin. The results suggest that the antibiotic susceptibility patterns cannot be applied to biofilm established infections. Selection of antimicrobial therapy is a critical step in DFI and should aim at overcoming biofilm disease in order to optimize the outcomes of this complex pathology.


  • Open Access

    Molecular typing, virulence traits and antimicrobial resistance of diabetic foot staphylococci

    by Carla Mottola, Teresa Semedo-Lemsaddek, João J. Mendes, José Melo-Cristino, Luís Tavares, Patrícia Cavaco-Silva, Manuela Oliveira

    Diabetes mellitus is a major chronic disease that continues to increase significantly. One of the most important and costly complications of diabetes are foot infections that may be colonized by pathogenic and antimicrobial resistant bacteria, harboring several virulence factors, that could impair its successful treatment. Staphylococcus aureus is one of the most prevalent isolate in diabetic foot infections, together with aerobes and anaerobes. In this study, conducted in the Lisbon area, staphylococci isolated (n = 53) from diabetic foot ulcers were identified, genotyped and screened for virulence and antimicrobial resistance traits. Genetic relationship amongst isolates was evaluated by pulsed-field-gel-electrophoresis with further multilocus sequence typing of the identified pulsotypes. PCR was applied for detection of 12 virulence genes and e-test technique was performed to determine minimal inhibitory concentration of ten antibiotics. Among the 53 isolates included in this study, 41 Staphylococcus aureus were identified. Staphylococcal isolates were positive for intercellular adhesins icaA and icaD, negative for biofilm associated protein bap and pantone-valentine leucocidin pvl. S. aureus quorum sensing genes agrI and agrII were identified and only one isolate was positive for toxic shock syndrome toxin tst. 36 % of staphylococci tested were multiresistant and higher rates of resistance were obtained for ciprofloxacin and erythromycin. Clonality analysis revealed high genomic diversity and numerous S. aureus sequence types, both community- and hospital-acquired, belonging mostly to clonal complexes CC5 and C22, widely diffused in Portugal nowadays. This study shows that diabetic foot ulcer staphylococci are genomically diverse, present resistance to medically important antibiotics and harbour virulence determinants. These properties suggest staphylococci can contribute to persistence and severity of these infections, leading to treatment failure and to the possibility of transmitting these features to other microorganisms sharing the same niche. In this context, diabetic patients may become a transmission vehicle for microorganisms’ clones between community and clinical environments.


    • 1 February 2012
      • Vol. 62  (1) , 37-48

    A rat model of diabetic wound infection for the evaluation of topical antimicrobial therapies.

    by João J Mendes, Clara I Leandro, Dolores P Bonaparte, Andreia L Pinto

    Diabetes mellitus is an epidemic multisystemic chronic disease that frequently is complicated by complex wound infections. Innovative topical antimicrobial therapy agents are potentially useful for multimodal treatment of these infections. However, an appropriately standardized in vivo model is currently not available to facilitate the screening of these emerging products and their effect on wound healing. To develop such a model, we analyzed, tested, and modified published models of wound healing. We optimized various aspects of the model, including animal species, diabetes induction method, hair removal technique, splint and dressing methods, the control of unintentional bacterial infection, sampling methods for the evaluation of bacterial burden, and aspects of the microscopic and macroscopic assessment of wound healing, all while taking into consideration animal welfare and the '3Rs' principle. We thus developed a new wound infection model in rats that is optimized for testing topical antimicrobial therapy agents. This model accurately reproduces the pathophysiology of infected diabetic wound healing and includes the current standard treatment (that is, debridement). The numerous benefits of this model include the ready availability of necessary materials, simple techniques, high reproducibility, and practicality for experiments with large sample sizes. Furthermore, given its similarities to infected-wound healing and treatment in humans, our new model can serve as a valid alternative for applied research.